Stockreport

Alexion wins early U.S. approval for rare blood disorder drug [Reuters]

STEMLINE THERAPEUTICS  (STML) 
Last stemline therapeutics earnings: 3/13 04:45 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.stemline.com/investor-relations
PDF Alexion wins early U.S. approval for rare blood disorder drug | Reuters 3 Min Read (Reuters) - The U.S. Food and Drug Administration approved on Friday Alexion Pharmaceu [Read more]